NeuroSense CFO Eisenberg joins ROTH Healthcare Opportunities Conference investor meetings

• NeuroSense to attend the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29, 2026, in New York City.
• CFO Or Eisenberg scheduled for one-on-one and small-group meetings with institutional investors during the event.
• Talks to focus on PrimeC clinical and regulatory progress, including plans to pursue potential approvals in Canada and the U.S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609281243PR_NEWS_USPR_____LN58242) on September 28, 2026, and is solely responsible for the information contained therein.